- Home
- Products
- Customized ADCs
- CD22
- Anti-CD22 (clone 10F4)-AcBut-Calicheamicin ADC
Anti-CD22 (clone 10F4)-AcBut-Calicheamicin ADC (CAT#: ADC-W-332)
This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4) conjugated via a AcBut linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Calicheamicin binds to DNA, causes DNA damage.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CD22
- Alternative Names
- CD22; CD22 molecule; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2;
- Target Entrez Gene ID
- 933
- Target UniProt ID
- P20273
- Overview
- CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.
CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.
- Overview
- Humanized Anti-CD22 Antibody
- Species Reactivity
- Human
- Name
- AcBut [-(4' acetyl phenoxy) butanoic acid]
- Description
- Disulfide Linkers, are extensively exploited as a chemically labile linkage. Since the release of disulfide-linked drugs requires a cytoplasmic thiol cofactor, such as glutathione (GSH). Disulfides maintain stable at physiological pH and only when ADCs are internalized inside cells, the cytosol provides reducing environment including intracellular enzyme protein disulfide isomerase, or similar enzymes, drugs can be released.
- Name
- calicheamicin
- Description
- Calicheamicin,produced by prokaryotic microorganisms, are a group of DNA cleaving agents with similar structure that binds in the minor grove of DNA in a relatively sequence-specific manner.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-C. diff toxin B (Bezlotoxumab)-SMCC-DM1 ADC (CAT#: ADC-W-2060)
- Anti-STEAP-1 (clone 120)-Mc-VC-PABC-MMAE ADC (CAT#: ADC-W-145)
- Anti-NOTCH1 (Brontictuzumab)-SPDB-DM4 ADC (CAT#: ADC-W-2361)
- Anti-DLL3 (clone SC16.15)-PBD dimers ADC (CAT#: ADC-W-102)
- Anti-MUC5A (Ensituximab)-MC-MMAF ADC (CAT#: ADC-W-1654)
- Anti-FcRL5 (clone 10A8)-SPDB-DM4 ADC (CAT#: ADC-W-401)
- Anti-NCA-90 (Lemalesomab)-SPDB-DM4 ADC (CAT#: ADC-W-2163)
- Anti-MUC1 (huC242)-SMCC-[3H]DM1 ADC (CAT#: ADC-W-234)
- Anti-RhD (Atorolimumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1722)
- Anti-GD3 (Ecromeximab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2022)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-332. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-2532 | Anti-CD22 (Pinatuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-2533 | Anti-CD22 (Pinatuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
ADC-W-2527 | Anti-CD22-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-2535 | Anti-CD22 (Pinatuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
ADC-W-2524 | Anti-CD22 (Inotuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
CAT# | Product Name | Linker | Payload |
ADC-W-019 | Anti-EFNA4 (clone huE47)-AcBut-CM ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | CM (N-acetyl-y-calicheamicin dimethyl hydrazide) |
ADC-W-008 | Anti-TPBG (clone A1)-AcBut-calicheamicin ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
ADC-W-018 | Anti-EFNA4 (clone huE22)-AcBut-CM ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | CM (N-acetyl-y-calicheamicin dimethyl hydrazide) |
ADC-W-459 | Anti-FUT3 (clone hu3S193)-AcBut-CalichDMH ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | CalichDMH |
ADC-W-357 | Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
CAT# | Product Name | Linker | Payload |
ADC-W-008 | Anti-TPBG (clone A1)-AcBut-calicheamicin ADC | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
ADC-W-338 | Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC | hydrazone | calicheamicin |
ADC-W-556 | Anti-EphA4-calicheamicin ADC | Calicheamicin | |
ADC-W-464 | Anti-CD33 (clone hP67.6)-AcBut-Calicheamicin ADC | AcBut (4-(4-acetylphenoxy)butanoic acid) | Calicheamicin |
WJY-0423-LS106 | Protein A-Calicheamicin ADC | Cleavable linkers | Calicheamicin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.